Morgan Stanley Bio Rad Laboratories, Inc. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

A detailed history of Morgan Stanley transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Morgan Stanley holds 712 shares of BIO-B stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
712
Previous 712 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024
SELL
N/A
-12 Reduced 1.66%
712 $0
Q2 2024

Aug 14, 2024
SELL
N/A
-12 Reduced 1.66%
712 $0
Q1 2024

Oct 17, 2024
BUY
N/A
12 Added 1.69%
724 $0
Q4 2023

Aug 16, 2024
BUY
N/A
12 Added 1.69%
724 $0
Q2 2022

Oct 27, 2022
BUY
N/A
32 Added 4.62%
724 $358,000
Q2 2022

Aug 15, 2022
BUY
N/A
32 Added 4.62%
724 $358,000
Q1 2022

Oct 27, 2022
SELL
N/A
-32 Reduced 4.42%
692 $389,000
Q3 2021

Nov 15, 2021
BUY
N/A
692 New
692 $514,000

Others Institutions Holding BIO-B

# of Institutions
7
Shares Held
3.33K
Call Options Held
0
Put Options Held
0
View Full List

About Bio-Rad Laboratories, Inc.

BIO-B Quotes by TradingView
  • Ticker BIO-B
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 5,063,720
  • Market Cap $11.2B
More about BIO-B
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email